Adevinta ASA (ADE) - Adevinta reports a solid start to the year, with strong financial performance in Q1
May 05, 2021 01:00 ET
|
Adevinta ASA
Total revenues1 up 6% at €200mEBITDA1 up 33% yoy to €57mSuccessful delivery of product roadmapFurther progress ahead of the eBay Classifieds Group acquisition Oslo, 5 May 2021 - Adevinta ASA...
Valneva Announces an Indicative Price Range of its Previously Announced Proposed Global Offering
May 05, 2021 01:00 ET
|
VALNEVA
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with...
Solvay first quarter 2021 results: Strong start to the year with double-digit growth in Cash and EBITDA and record EBITDA margins
May 05, 2021 01:00 ET
|
Solvay S.A.
Register now to the webcast scheduled at 15:00 CESTLink to financial report Solvay first quarter 2021 resultsStrong start to the year with double-digit growth in Cash and EBITDA and record EBITDA...
Interim report January–March 2021: Strong demand in building solutions in Europe and North America drive the increase in comparable operating profit
May 05, 2021 01:00 ET
|
Uponor Corporation
Uponor Corporation Stock exchange release 5 May 2021 08:00 EET Interim report January–March 2021: Strong demand in building solutions in Europe and North America drive the increase in...
Addex Reports Q1 2021 Financial Results and Provides Corporate Update
May 05, 2021 01:00 ET
|
Addex Therapeutics
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M)Completed $11.5M fundraising in January 2021Three clinical studies in neurology programs remain on track to start during...
Roche’s Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
May 05, 2021 01:00 ET
|
F. Hoffmann-La Roche Ltd
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in a Phase III studyTecentriq approval offers an alternative to chemotherapy for all...
Transparency Notification Received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
May 05, 2021 01:00 ET
|
Celyad Oncology SA
MONT-SAINT-GUIBERT, Belgium, May 05, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of...
Three-month interim report (Q1) 2021
May 05, 2021 00:57 ET
|
ALK Abello
ALK reports 9% sales growth in Q1 fuelled by better than expected tablet growth of 32% (unaudited) The first three months of 2021 represented ALK’s best-ever quarter, with revenue exceeding DKK 1...
Uponor updates the savings target and schedule of its operational excellence programme
May 05, 2021 00:50 ET
|
Uponor Corporation
Uponor Corporation Investor news 5 May 2021 07:50 EET Uponor updates the savings target and schedule of its operational excellence programme Uponor communicated in its...
Clean Power Capital Provides Update on Its Investment in FusionOne‘s Waste to Electricity and Hydrogen Technology
May 05, 2021 00:37 ET
|
Clean Power Capital Corp.
VANCOUVER, British Columbia and IRVINE, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or "MOVE"). The Company...
- 08 juin 2024 09h00 HE Rogers lance un concours national pour la finale de la Coupe Stanley pour la clientèle
- 07 juin 2024 10h00 HE Le béluga et le renard arctique sont les nouveaux sujets des vidéos de FFDP